Interim estimates of 2016–17 seasonal influenza vaccine effectiveness — United States, February 2017

Morbidity and Mortality Weekly Report

Volumn 66, Issue 6, 2017, Pages 167-171

  Flannery, Brendan ^a   Chung, Jessie R ^a   Thaker, Swathi N ^a   Monto, Arnold S ^b   Martin, Emily T ^b   Belongia, Edward A ^c   McLean, Huong Q ^c   Gaglani, Manjusha ^d   Murthy, Kempapura ^d   Zimmerman, Richard K ^e,f   Nowalk, Mary Patricia ^e,f   Jackson, Michael L ^g   Jackson, Lisa A ^g   Foust, Angie ^a   Sessions, Wendy ^a   Berman, Lashondra ^a   Spencer, Sarah ^a   Fry, Alicia M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MARSHFIELD CLINIC   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PRESCHOOL CHILD; SEASON; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 85013632417     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6606a3     Document Type: Note

References (10)

1. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2016-17 influenza season. MMWR Recomm Rep 2016;65(No. RR5). http://dx.doi.org/10.15585/mmwr.rr6505a1
2. CDC. Fluview. 2016-2017 influenza season week 6 ending February 11, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/flu/weekly
3. Zimmerman RK, Nowalk MP, Chung J, et al. 2014-2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis 2016;63:1564-73. http://dx.doi.org/10.1093/cid/ciw635
4. Flannery B, Zimmerman RK, Gubareva LV, et al. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. J Infect Dis 2016;214:1010-9. http://dx.doi.org/10.1093/infdis/jiw181
5. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014;58:319-27. http://dx.doi.org/10.1093/cid/cit736
6. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2015;211:1529-40. http://dx.doi.org/10.1093/infdis/jiu647
7. Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 2016;16:942-51. http://dx.doi.org/10.1016/S1473-3099(16)00129-8
8. Barr IG, Russell C, Besselaar TG, et al. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1) pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine 2014;32:4713-25. http://dx.doi.org/10.1016/j.vaccine.2014.02.014
9. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR1).
10. CDC. FluVaxView. Influenza vaccination coverage. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https://www.cdc.gov/flu/fluvaxview/index.htm